SEC Filing Details

Document Details

Form
SCHEDULE 13G
Filing Date
Mar 1, 2024
Document Date
Mar 1, 2024
Form Description
SCHEDULE 13G - Description
Company
Bellerophon Therapeutics, Inc.
Issuer
BELLEROPHON THERAPEUTICS, INC.